Inhibidores de enzima convertidora o bloqueadores de receptores AT1 [PDF]
, 2001 Sergio Treventhan Cravioto
openalex
[Impact of P-CABs in the Treatment of Acid-related Diseases: an Evidence Review]. [PDF]
Acta Gastroenterol LatinoamRemes-Troche JM +2 more
europepmc +1 more source
[Dilated cardiomyopathy and conduction disorder due to <i>TNNI3K</i> mutation]. [PDF]
Arch Cardiol MexGayán-Ordás J +5 more
europepmc +1 more source
Are changes in olanzapine-induced liver enzyme levels associated with GSTT1, GSTM1, GSTP1, and OGG1 gene polymorphisms? [PDF]
Arh Hig Rada ToksikolElkama A, İlik N, Ak M, Karahalil B.
europepmc +1 more source
Treating Patients with Heart Failure with Reduced Ejection Fraction (HFrEF) and Atrial Fibrillation: We Need to Talk About the Fifth Pillar. [PDF]
Arq Bras CardiolPimentel M +4 more
europepmc +1 more source
A gap in the prognostic score for atherosclerotic renovascular disease: the role of statins. [PDF]
J Bras NefrolCampos RP.
europepmc +1 more source
Therapeutic competitions and frailty among older adults in São Paulo city: a cross-sectional population-based study, 2015. [PDF]
Epidemiol Serv SaudeSouza IG +5 more
europepmc +1 more source
[Flagellate erythema secondary to bleomycin: case report with favorable outcome]. [PDF]
Rev Med Inst Mex Seguro SocLeal-León R +4 more
europepmc +1 more source
Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspective. [PDF]
J Bras NefrolRico-Fontalvo J +8 more
europepmc +1 more source
Estudo das características físicos-químicas de lipase de Aspergillus niger visando sua aplicação em alimentos. [PDF]
, 2014 COURI, S. +4 more
core